Biotechnology Stocks I Performance Guide: Intellia Therapeutics, Inc. (NTLA)
NTLA has no dividends
Table and Chart of NTLA Performance
See what a $1,000 investment in NTLA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NTLA Returns | |
|---|---|
| Start Date | Jun-30-2016 |
| Start Price | $21.35 |
| End Date | Dec-01-2023 |
| End Price | $30.84 |
| # Prices | 91 |
| Min Date | May-31-2017 |
| Min Price | $11.46 |
| Max Date | Jun-30-2021 |
| Max Price | $161.91 |
| Total Return | 44.45% |
| Annualized Return | 4.97% |
| Current Value of $1,000 Purchase | $1,444 |
| Number Returns | 4,095 |
| Average Return | 143.32% |
| Number Profitable Returns | 2,806 |
| Percent Profitable Returns | 68.52% |
| Number Unprofitable Returns | 1,289 |
| Percent Unprofitable Returns | 31.48% |
| Profitable to Unprofitable Returns Ratio | 2.18 |
| NTLA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,761,873,000 | Price to Sales | 53.35 |
| Earnings per Share | $-5.3400 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 2.661 |
| PRICE DATA | |
| 52 Week High | $47.48 |
| 52 Week Low | $22.66 |
| Analyst Target Price | $76 |
| 50-Day Moving Average | $28.48 |
| 200-Day Moving Average | $37.0 |
| FINANCIAL DATA | |
| Revenue per Share | $0.599 |
| Revenue | $51,765,000 |
| Profit Margin | 0% |
| Return on Equity | -0.497% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NTLA Compare Returns with S&P 500
NTLA Trendline Chart